RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Venus Medtech Hangzhou Stock

Venus Medtech Hangzhou Net Income 2025

Venus Medtech Hangzhou Net Income

-292.39 M CNY

Ticker

2500.HK

ISIN

CNE100003PJ8

In 2025, Venus Medtech Hangzhou's profit amounted to -292.39 M CNY, a -35.64% increase from the -454.33 M CNY profit recorded in the previous year.

The Venus Medtech Hangzhou Net Income history

YEARNET INCOME (undefined CNY)
2029e-
2028e-
2027e-
2026e-
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-

Venus Medtech Hangzhou Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Venus Medtech Hangzhou, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Venus Medtech Hangzhou from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Venus Medtech Hangzhou’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Venus Medtech Hangzhou. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Venus Medtech Hangzhou’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Venus Medtech Hangzhou’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Venus Medtech Hangzhou’s growth potential.

Venus Medtech Hangzhou Revenue, EBIT and net profit per share

DateVenus Medtech Hangzhou RevenueVenus Medtech Hangzhou EBITVenus Medtech Hangzhou Net Income
2029e4.51 B undefined1.06 B undefined0 undefined
2028e3.76 B undefined896.31 M undefined0 undefined
2027e2.92 B undefined678.65 M undefined0 undefined
2026e807.59 M undefined-119.43 M undefined-112.46 M undefined
2025e738.47 M undefined-264.73 M undefined-292.39 M undefined
2024e579 M undefined-434.2 M undefined-454.33 M undefined
2023491.37 M undefined-718.25 M undefined-703.75 M undefined
2022406.46 M undefined-1.19 B undefined-1.06 B undefined
2021415.86 M undefined-420.25 M undefined-373.64 M undefined
2020276.05 M undefined-262.4 M undefined-181.99 M undefined
2019233.27 M undefined-363.61 M undefined-380.72 M undefined
2018115.35 M undefined-305.8 M undefined-300.42 M undefined
201718.16 M undefined-155.96 M undefined-156.53 M undefined

Venus Medtech Hangzhou stock margins

The Venus Medtech Hangzhou margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Venus Medtech Hangzhou. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Venus Medtech Hangzhou.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Venus Medtech Hangzhou's sales revenue. A higher gross margin percentage indicates that the Venus Medtech Hangzhou retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Venus Medtech Hangzhou's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Venus Medtech Hangzhou's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Venus Medtech Hangzhou's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Venus Medtech Hangzhou. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Venus Medtech Hangzhou's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Venus Medtech Hangzhou Margin History

Venus Medtech Hangzhou Gross marginVenus Medtech Hangzhou Profit marginVenus Medtech Hangzhou EBIT marginVenus Medtech Hangzhou Profit margin
2029e79.21 %23.57 %0 %
2028e79.21 %23.83 %0 %
2027e79.21 %23.25 %0 %
2026e79.21 %-14.79 %-13.93 %
2025e79.21 %-35.85 %-39.59 %
2024e79.21 %-74.99 %-78.47 %
202379.21 %-146.17 %-143.22 %
202277.25 %-293.31 %-260.22 %
202177.99 %-101.05 %-89.85 %
202082.33 %-95.05 %-65.93 %
201983.45 %-155.88 %-163.21 %
201885.81 %-265.11 %-260.45 %
201783.06 %-858.62 %-861.77 %

Venus Medtech Hangzhou Aktienanalyse

What does Venus Medtech Hangzhou do?

Venus Medtech Hangzhou Inc. is a medical technology company specializing in the development, manufacturing, and marketing of minimally invasive heart valve implants. Venus Medtech Hangzhou ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Venus Medtech Hangzhou's Profit Margins

The profit margins of Venus Medtech Hangzhou represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Venus Medtech Hangzhou's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Venus Medtech Hangzhou's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Venus Medtech Hangzhou's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Venus Medtech Hangzhou’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Venus Medtech Hangzhou stock

How much profit has Venus Medtech Hangzhou made this year?

Venus Medtech Hangzhou has made -292.39 M CNY this year.

How has the profit developed compared to last year?

The profit has increased by -35.64% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Venus Medtech Hangzhou publish its earnings?

Venus Medtech Hangzhou publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Venus Medtech Hangzhou?

The profits of Venus Medtech Hangzhou are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Venus Medtech Hangzhou?

You can learn more about the earnings of Venus Medtech Hangzhou by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Venus Medtech Hangzhou pay?

Over the past 12 months, Venus Medtech Hangzhou paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Venus Medtech Hangzhou is expected to pay a dividend of 0 CNY.

What is the dividend yield of Venus Medtech Hangzhou?

The current dividend yield of Venus Medtech Hangzhou is .

When does Venus Medtech Hangzhou pay dividends?

Venus Medtech Hangzhou pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Venus Medtech Hangzhou?

Venus Medtech Hangzhou paid dividends every year for the past 0 years.

What is the dividend of Venus Medtech Hangzhou?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Venus Medtech Hangzhou located?

Venus Medtech Hangzhou is assigned to the 'Health' sector.

Wann musste ich die Aktien von Venus Medtech Hangzhou kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Venus Medtech Hangzhou from 2/1/2025 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 2/1/2025.

When did Venus Medtech Hangzhou pay the last dividend?

The last dividend was paid out on 2/1/2025.

What was the dividend of Venus Medtech Hangzhou in the year 2024?

In the year 2024, Venus Medtech Hangzhou distributed 0 CNY as dividends.

In which currency does Venus Medtech Hangzhou pay out the dividend?

The dividends of Venus Medtech Hangzhou are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Venus Medtech Hangzhou

Our stock analysis for Venus Medtech Hangzhou Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Venus Medtech Hangzhou Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.